GenScript
In Brief This Week: Orgenesis, Merck, 23andMe, AstraZeneca, Genenta Science, GenScript
News items for the week of Feb. 27, 2023.
OncoOne, GenScript ProBio Enter Agreement to Develop Monoclonal Antibodies Targeting oxMIF
With this partnership, OncoOne said it expects to have its first two oxMIF candidates enter Phase I clinical trials in 2023.